Difference between revisions of "Protein synthesis initiation factor 5A (TG2)"
| Line 37: | Line 37: | ||
|- | |- | ||
| Surface accessibility | | Surface accessibility | ||
| − | | [http://gibk21.bse.kyutech.ac.jp/asaview/all/ | + | | [http://gibk21.bse.kyutech.ac.jp/asaview/all/1eif.pdf ASAView] pdf |
| + | [http://gibk21.bse.kyutech.ac.jp/asaview/all/1eif.txt ASAView] txt | ||
|- | |- | ||
| Disorder prediction | | Disorder prediction | ||
Revision as of 07:46, 25 July 2007
| Template:Infobox header| Protein synthesis initiation factor 5A (TG2) | |
|---|---|
| Protein synthesis initiation factor 5A (TG2) | |
| Substrate peptide name | Protein synthesis initiation factor 5A (TG2) |
| Synonyms | Rev-binding factor
eIF-5A |
| Determination type | In vitro |
| Source | Homo sapiens |
| Subcellular localization | Cytosol |
| Swissprot ID | P63241 |
| Reactive glutamines | - |
| Reactive lysines | Hypusine 50 |
| Substrate sequence | TSKTGKHGHAK |
| Structure | 1EIF |
| Surface accessibility | ASAView pdf
ASAView txt |
| Disorder prediction | IUPred |
| Reference | PMID:7848270 |
| Notes | Hypusine is a post-translational modification of lysine by the addition of a butylamino group |
| Template:Infobox header | | |
.png){kind=link}